(+)-(2E,4E,6Z,8E)-3,7-Dimethyl-9-[(3R,6R)-6-methyl-3-(prop-1-en-2-yl)-cyclohex-1-ene]nona-2,4,6,8-tetraenoic Acid

ID: ALA2021516

PubChem CID: 70683410

Max Phase: Preclinical

Molecular Formula: C21H30O2

Molecular Weight: 314.47

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  C=C(C)[C@@H]1CC[C@@H](C)C(/C=C/C(C)=C\C=C\C(C)=C\C(=O)O)C1

Standard InChI:  InChI=1S/C21H30O2/c1-15(2)19-12-10-18(5)20(14-19)11-9-16(3)7-6-8-17(4)13-21(22)23/h6-9,11,13,18-20H,1,10,12,14H2,2-5H3,(H,22,23)/b8-6+,11-9+,16-7-,17-13+/t18-,19-,20?/m1/s1

Standard InChI Key:  ICHOXYDNXCNWBS-FRRZSWROSA-N

Molfile:  

     RDKit          2D

 23 23  0  0  0  0  0  0  0  0999 V2000
    3.9261  -12.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2116  -12.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4971  -12.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4971  -13.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2116  -14.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9261  -13.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2116  -14.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.9261  -15.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.4971  -15.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.6406  -12.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2116  -11.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.3550  -12.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0695  -12.3750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7840  -12.7875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.0695  -11.5500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7840  -13.6125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4984  -14.0250    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4984  -14.8500    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2129  -15.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.7840  -15.2625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.2129  -16.0875    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9274  -16.5000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    7.4984  -16.5000    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  1  0
  2  3  1  0
  3  4  1  0
  4  5  1  0
  5  6  1  0
  6  1  1  0
  5  7  1  6
  7  8  2  0
  7  9  1  0
  1 10  1  0
  2 11  1  1
 10 12  2  0
 12 13  1  0
 13 14  2  0
 13 15  1  0
 14 16  1  0
 16 17  2  0
 17 18  1  0
 18 19  2  0
 18 20  1  0
 19 21  1  0
 21 22  2  0
 21 23  1  0
M  END

Associated Targets(Human)

RARB Tclin Retinoic acid receptor beta (1232 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARA Tclin Retinoic acid receptor alpha (1324 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
RARG Tclin Retinoic acid receptor gamma (1154 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 314.47Molecular Weight (Monoisotopic): 314.2246AlogP: 5.70#Rotatable Bonds: 6
Polar Surface Area: 37.30Molecular Species: ACIDHBA: 1HBD: 1
#RO5 Violations: 1HBA (Lipinski): 2HBD (Lipinski): 1#RO5 Violations (Lipinski): 1
CX Acidic pKa: 4.70CX Basic pKa: CX LogP: 5.55CX LogD: 2.90
Aromatic Rings: Heavy Atoms: 23QED Weighted: 0.39Np Likeness Score: 2.27

References

1. Alvarez S, Pazos-Randulfe Y, Khanwalkar H, Germain P, Alvarez R, Gronemeyer H, de Lera AR..  (2008)  New retinoid chemotypes: 9-cis-retinoic acid analogs with hydrophobic rings derived from terpenes as selective RAR agonists.,  16  (22): [PMID:18951029] [10.1016/j.bmc.2008.09.069]

Source